CompuGROUP Experiences Strong Increase of Revenues

CompuGROUP Holding AGBoth revenues and earnings of CompuGROUP have increased significantly in the business year 2007, and the company is now looking back on the most successful business year in its history. All projected revenues and targeted results have been met. Both the Health Provider Services (HPS) and Health Connectivity Services (HCS) segments have shown an excellent development compared to the previous year's results and are meeting the company's expectations. Due to further investments in the strategically important vita-X product - web-based electronic patient file - the Electronic Patient Services segment (EPS) could improve its results only marginally.

Strong Revenue Growth
In the business year 2007, consolidated revenues increased by 28.6 percent to EUR 180.2 million. In the HPS segment, revenues increased by 22.9 percent to EUR 104.6 million. HCS segment revenues increased by 27.1 percent to EUR 72.8 million. The EPS segment reached revenues in the amount of EUR 5.2 million, thus also showing a slight increase.

Adjusted Group EBITDA improved by 34.7 Percent
The adjusted consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 34.7 percent to EUR 51.6 million in the past business year. In the HPS segment, EBITDA increased by 49.8 percent compared to the last year to an amount of EUR 22.7 million. The HCS segment continues to show strong profitability with an EBITDA of EUR 37.5 million in the business year 2007. Another improvement could be achieved in the EPS segment. Here the EBITDA is EUR -2.6 million.

Net Income has doubled: EUR 22.84 Million – Cash Earnings per Share have risen to EUR 0.78
The costs of the IPO as well as a revaluation of deferred taxes due to lowered corporate taxes had the expected positive, yet exceptional influence of EUR 7.7 million on the reported tax rate. As a result, the annual net income increased above average by 100.5 percent to EUR 22.8 million. The adjusted earnings per share (Cash EPS based on Cash Net Income) amount to EUR 0.78 compared to EUR 0.55 in the previous business year. This reflects a PE of about 15 for the year 2007. In the light of CompuGROUP's strong penchant for growth, it is clear that the company's shares promise to perform particularly well in the future.

Highlights in 2007
In 2007 CompuGROUP has further strengthened its international presence and consistently invested in the strategic expansion of all three business segments HPS, HCS and EPS.

Thus the company's basis for further growth in the international market has once more expanded significantly: Its access to doctors in governmental healthcare in Europe has increased remarkably. No other eHealth provider on the continent has such a large customer basis of doctors in governmental healthcare as CompuGROUP.

The newest pillar of CompuGROUP's business model – the company's portfolio of innovative software products for hospitals and clinics – has turned into a success story right after its introduction. The integration of hospitals into CompuGROUP's network offers them completely new perspectives when it comes to increasing their efficiency in times of ever-rising costs.

Faced with ongoing, massive structural changes of the German healthcare system which focus primarily on new concepts for the allocation of medical care, CompuGROUP responded with a ground-breaking innovation in 2007: For the first time, the history of complex medical treatments can be tracked and electronically mapped for individual patients to be supplemented with software-based suggestions for treatment in the managed care context. CompuGROUP has developed a complete software solution for the mapping of comprehensive managed care contracts covering a large variety of medical indications. A high demand for such solutions in the future from both governmental as well as private health insurances are expected.

Number of Employees Has Grown
As of December 31, 2007, the holding employed a total of 1,692 persons. This represents a 28-percent increase or 371 persons compared to the previous year.

Outlook for 2008: Further Growth of Revenues and EBITDA
Based on the product portfolio's further strategic development across all segments, as well as on the continuously fostered market cultivation and increasing demand for CompuGROUP's products, an even stronger business growth surpassing the results of 2007 is expected. For the business year 2008, the management board of CompuGROUP expects consolidated revenues of at least EUR 215 million and an EBITDA of at least EUR 65 million.

Related news articles:

About CompuGROUP Holding AG
CompuGROUP is one of the leading eHealth companies in Europe. Its software products, designed to support all medical and organizational activities in doctors’ surgeries and hospitals, its information services for all involved parties within the healthcare system and its web-based personal health records contribute to safer and more efficient healthcare. The services of CompuGROUP are centered on its unique customer base of around 300,000 doctors, dentists, hospitals, associations and networks as well as other service providers. CompuGROUP operates in 9 European countries and currently employs around 1,800 people. For more information, visit www.compugroup.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...